- Latest SUV offering delivers extended tread life, enhanced safety in wet and snowy conditions, and industry-leading cabin comfort - Dynapro lineup now includes range of products built to handle...

Rollins, Inc. (NYSE: ROL) ("Rollins" or the "Company"), a premier global consumer and commercial services company, today announced that Rollins Executive Vice President and Chief Financial...

Preparing organizations for the next trust frontier through knowledge and cutting-edge AI Governance solutions BOSTON, Nov. 2, 2023 /PRNewswire/ -- IAPP AI Governance Global 2023 -- OneTrust, the...

-- Growing body of data on REZLIDHIA® (olutasidenib) in mIDH1 relapsed or refractory (R/R) acute myeloid leukemia (AML) patients -- -- New data on olutasidenib in patients with mIDH1...

Lishan Aklog, M.D., Chairman & CEO, to Present November 16, 2023, in New York NEW YORK, Nov. 2, 2023 /PRNewswire/ -- Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company") a...

Auxora™ showed a 53% reduction in days in hospital, a 40% reduction in intensive care unit (ICU) days and eliminated the need for total parenteral nutrition (TPN) LA JOLLA, Calif., Nov. 2, 2023...

Amanda Seyfried on Banned Books, Ilana Glazer and Dr. Ayana Elizabeth Johnson on Climate, Allie Phillips on Abortion Bans, and More Among Speakers at 2nd Annual Summit NEW YORK, Nov. 2, 2023...

Subaru of America, Inc. today announced an all-new fully redesigned vehicle will make its global debut at 9:40 a.m. PT (12:40 p.m. ET) on November 16 at the 2023 Los Angeles Auto Show. Please...

– Additional data from pivotal AUGMENT-101 trial in R/R KMT2Ar acute leukemia further highlight revumenib's potential best-in-class profile – – 100% ORR (n=7) and manageable safety profile...

Oral presentation will showcase distinct preclinical profile for potent, selective MALT1 scaffolding inhibitor that is highly differentiated from MALT1 protease inhibitors BOSTON, Nov. 2, 2023...